Ikarian Capital, LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$1.4M
Holdings
173
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (173 positions)
| Stock | Value |
|---|---|
MREOMEREO BIOPHARMA GROUP PLC | $322.0M |
ASLNASLAN PHARMACEUTICALS LTD | $288.0M |
SPYSPDR S&P 500 ETF TR | $128.7M |
XBISPDR SER TR | $119.4M |
TCE2CELLDEX THERAPEUTICS INC NEW | $85.4M |
RETAEURREATA PHARMACEUTICALS INC | $58.5M |
BIIBBIOGEN INC | $56.5M |
HZNPHORIZON THERAPEUTICS PUB L | $49.0M |
UNHUNITEDHEALTH GROUP INC | $39.1M |
ALNYALNYLAM PHARMACEUTICALS INC | $34.2M |
SRPTSAREPTA THERAPEUTICS INC | $34.1M |
CMPSCOMPASS PATHWAYS PLC | $32.2M |
RFLRAFAEL HLDGS INC | $30.5M |
APLSAPELLIS PHARMACEUTICALS INC | $30.5M |
KRYSKRYSTAL BIOTECH INC | $30.0M |
BCYCBICYCLE THERAPEUTICS PLC | $27.3M |
CRSPCRISPR THERAPEUTICS AG | $25.2M |
ALLKGUSDALLAKOS INC | $23.3M |
CCXIEURCHEMOCENTRYX INC | $20.5M |
ZNTLZENTALIS PHARMACEUTICALS INC | $19.5M |
GOSSGOSSAMER BIO INC | $19.3M |
XENEXENON PHARMACEUTICALS INC | $17.6M |
KODKODIAK SCIENCES INC | $16.1M |
QNCXCORTEXYME INC | $14.9M |
NVV1NOVAVAX INC | $14.8M |
CABACABALETTA BIO INC | $14.4M |
ASNSUSDX4 PHARMACEUTICALS INC | $13.4M |
MGNXMACROGENICS INC | $13.3M |
MRTXEURMIRATI THERAPEUTICS INC | $12.6M |
—SIERRA ONCOLOGY INC | $12.6M |
EDITEDITAS MEDICINE INC | $12.5M |
IMTXIMMATICS N.V | $11.5M |
MRKMERCK & CO INC | $11.3M |
AM6AMICUS THERAPEUTICS INC | $10.7M |
TCONTRACON PHARMACEUTICALS INC | $10.4M |
MISTMILESTONE PHARMACEUTICALS IN | $10.0M |
1K0IGM BIOSCIENCES INC | $10.0M |
—DICERNA PHARMACEUTICALS INC | $10.0M |
INBXUSDINHIBRX INC | $9.7M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $9.1M |
INCYINCYTE CORP | $9.0M |
—ZOGENIX INC | $9.0M |
ARNAEURARENA PHARMACEUTICALS INC | $8.9M |
ITCIEURINTRA-CELLULAR THERAPIES INC | $7.9M |
OCULOCULAR THERAPEUTIX INC | $7.7M |
PCVXVAXCYTE INC | $7.5M |
OPHTEURIVERIC BIO INC | $6.8M |
ELANELANCO ANIMAL HEALTH INC | $6.4M |
—AYALA PHARMACEUTICALS INC | $6.1M |
AZNASTRAZENECA PLC | $6.0M |
SCPHSCPHARMACEUTICALS INC | $6.0M |
FATEFATE THERAPEUTICS INC | $5.9M |
BCABBIOATLA INC | $5.8M |
—ODONATE THERAPEUTICS INC | $5.4M |
ALDXALDEYRA THERAPEUTICS INC | $5.3M |
ATYRATYR PHARMA INC | $5.1M |
RLAYRELAY THERAPEUTICS INC | $5.0M |
CLVSEURCLOVIS ONCOLOGY INC | $5.0M |
CMRXEURCHIMERIX INC | $5.0M |
AVIRATEA PHARMACEUTICALS INC | $4.9M |
WVEWAVE LIFE SCIENCES LTD | $4.9M |
ACADACADIA PHARMACEUTICALS INC | $4.7M |
BLUBELLUS HEALTH INC NEW | $4.6M |
GLPGGALAPAGOS NV | $4.5M |
AUPHAURINIA PHARMACEUTICALS INC | $4.4M |
MCRB1EURSERES THERAPEUTICS INC | $4.2M |
—FINCH THERAPEUTICS GROUP INC | $4.1M |
—RENOVACOR INC | $4.0M |
VSTMVERASTEM INC | $3.8M |
OVIDOVID THERAPEUTICS INC | $3.7M |
LYRALYRA THERAPEUTICS INC | $3.7M |
CRVSCORVUS PHARMACEUTICALS INC | $3.7M |
BCRXBIOCRYST PHARMACEUTICALS INC | $3.6M |
AUTLAUTOLUS THERAPEUTICS PLC | $3.6M |
TREURTRILLIUM THERAPEUTICS INC | $3.5M |
NXTCNEXTCURE INC | $3.4M |
CLNNEURCLENE INC | $3.3M |
TARAPROTARA THERAPEUTICS INC | $3.3M |
TGTXTG THERAPEUTICS INC | $3.3M |
VINCVINCERX PHARMA INC | $3.2M |
PHATPHATHOM PHARMACEUTICALS INC | $3.2M |
CMMBCHEMOMAB THERAPEUTICS LTD | $3.2M |
VKTXVIKING THERAPEUTICS INC | $3.1M |
1T7TRICIDA INC | $3.1M |
—DBV TECHNOLOGIES S A | $3.1M |
TORCEURADICET BIO INC | $3.1M |
ARKGARK ETF TR | $3.1M |
—SATSUMA PHARMACEUTICALS INC | $2.9M |
—AILERON THERAPEUTICS INC | $2.8M |
STROSUTRO BIOPHARMA INC | $2.5M |
LQDALIQUIDIA CORPORATION | $2.4M |
SNPXSYNAPTOGENIX INC | $2.4M |
SYBXSYNLOGIC INC | $2.4M |
—YUMANITY THERAPEUTICS INC | $2.4M |
ELDNELEDON PHARMACEUTICALS INC | $2.1M |
YB4PSAVARA INC | $2.1M |
NKTREURNEKTAR THERAPEUTICS | $2.1M |
—CODIAK BIOSCIENCES INC | $2.0M |
—HEALTH SCIENCES ACQ CORP 2 | $1.9M |
MDGLMADRIGAL PHARMACEUTICALS INC | $1.9M |
Page 1 of 2Next